What do drug discovery, the creator economy, and AI vision models have in common? For @metanova_labs, @Bitcast_network, and @webuildscore, the answer is Bittensor. Each company uses a Bittensor subnet to marshal decentralized work (molecule candidate selection, creator video products, and specialized vision models, respectively) against their defined problem set. As a result, the speed at which we can find new drugs, the ease with which brands can find and work with new creators, and the…